About
Amaryllis Therapeutics develops peptides that target unique glycan signatures to deliver therapeutics across the blood-brain barrier, focusing on treatment delivery to the brain.
Explore Amaryllis Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.